The hidden atherogenic burden of lipoprotein(a): Reclassification by risk-weighted apoB in a multicenter registry.
BACKGROUND AND AIMS Apolipoprotein B (apoB) is the preferred marker of atherogenic particle burden, but it assumes that all apoB-containing lipoproteins confer the same cardiovascular risk. Mendelian randomization studies suggest that triglyceride-rich lipoproteins (TRLs) and lipoprotein(a) [Lp(a)] are more atherogenic...